ArticlePlanta2025
Doubling down on groundnut bud necrosis virus: combined dsRNAs targeting non-structural (NSs) and nucleocapsid (NP) genes confer superior resistance.
Article in Planta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
MAIN
conclusionThis study demonstrates that dsRNA targeting NSs and NP genes of GBNV effectively reduces viral titre and symptoms, strengthening RNAi defenses and offering a sustainable, eco-friendly approach for crop protection. Groundnut bud necrosis virus (GBNV), a highly destructive Orthotospovirus endemic to the Indian subcontinent, presents a major challenge due to the lack of resistant cultivars and rising insecticide resistance in vector populations. In this study, we evaluated the effectiveness of exogenously applied double-stranded RNAs (dsRNAs) targeting the non-structural (NSs) and nucleocapsid protein (NP) genes of GBNV in inducing RNA interference (RNAi)-mediated resistance. Two dsRNAs were expressed in Escherichia coli HT115 and exogenously applied to Nicotiana benthamiana and Vigna unguiculata (cowpea cv. Pusa Komal) as aqueous suspensions (10 µg/seedling), either individually or in combination (5 µg each). Following GBNV inoculation, untreated controls displayed severe local and systemic symptoms, while dsRNA-treated plants exhibited delayed symptom onset and reduced disease severity. Combined dsRNA treatment resulted in an 87% reduction in disease severity in cowpea and 54% in N. benthamiana. Quantitative real-time PCR revealed significant reductions in viral transcript levels: ~ 35-fold in cowpea and ~ 38-fold in N. benthamiana with combined dsRNAs, compared to 15- and 20-fold (dsNP alone) and 5- and 13-fold (dsNSs alone), respectively. The GBNV Protection Index (GBNVPI) was highest for the combined dsRNA (0.98 in cowpea, 0.90 in N. benthamiana), followed by dsNP (0.92 and 0.78) and dsNSs (0.75 and 0.70). Northern-blot analysis confirmed the generation of virus-derived siRNAs, indicating activation of the RNAi pathway. Overall, cowpea exhibited stronger protection than N. benthamiana. These results demonstrated that co-application of dsRNAs targeting dual genes of GBNV significantly enhanced RNAi-mediated resistance, representing a promising strategy for managing this virus in susceptible crops.
Indexed as
Identifiers
40996553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.